Anna Lena Lahmann

Anna Lena Lahmann

Auto-generated profile, based on publicly available information

Anna Lena Lahmann

Deutsches Herzzentrum München, Technische Universität München , Munich, Germany

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2017 in Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
Yukinori HaradaYukinori Harada
Yukinori Harada
JMJonathan Michel
Jonathan Michel
RLRaphaela Lohaus
Raphaela Lohaus
KMKatharina Mayer
Katharina Mayer
RERoberto Emmer
Roberto Emmer
SSStefanie Schulz-Schüpke
Stefanie Schulz-Schüpke
The DAPT score is a recently-proposed decision tool for guiding optimal duration of dual antiplatelet therapy (DAPT). It showed modest accuracy in prior derivation and validation cohorts of patients with ≥12 months DAPT. This study was aimed to evaluate the validity of the DAPT score in a cohort of patients with 6 or 12 months DAPT after implantation of predominantly second-generation drug-eluting stents. We analyzed data of patients enrolled in the ISAR-SAFE trial. Patients were classified into low (<2) or high (≥2) DAPT score groups. Primary ischaemic (all-cause death, myocardial infarction, definite stent thrombosis or stroke) and bleeding (TIMI major or minor) outcomes were analyzed in the low and high DAPT score groups. Data of 3976 patients were available for DAPT score calculation. 2407 patients (60.5%) were classified in the low DAPT score group and 1569 patients (39.5%) in the high DAPT score group. In the low DAPT score group there were no significant differences between 6 and 12 months DAPT regarding ischaemic (1.0% vs. 1.4%, HR=0.74, 95% CI, 0.35–1.57; p=0.43) or bleeding outcomes (0.3% vs. 0.8%, HR=0.44, 95% CI, 0.13–1.42; p=0.17). In the high DAPT score group there were also no significant differences between 6 and 12 months DAPT regarding ischaemic (1.9% vs. 1.8%, HR=1.02, 95% CI, 0.49–2.14; p=0.96) or bleeding (0.3% vs. 0.5%, HR=0.51, 95% CI, 0.09–2.78; p=0.44) outcomes. In conclusion, the DAPT score failed to show a differential treatment effect in patients receiving 6 or 12 months DAPT after contemporary drug-eluting stent implantation.

1 June 2018 in EuroIntervention
Verified
Journal Article
Closed access
SCSalvatore Cassese
Salvatore Cassese
Gjin NdrepepaGjin Ndrepepa
Gjin Ndrepepa
RBRobert A. Byrne
Robert A. Byrne
SKSebastian Kufner
Sebastian Kufner
ALAnna Lena Lahmann
Anna Lena Lahmann
MJMichael Joner
Michael Joner
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

25 February 2020 in Molecules
Verified
Journal Article
Open access
PDF file
TLTobias Lenz
Tobias Lenz
PNPhilipp Nicol
Philipp Nicol
MCMaria Isabel Castellanos
Maria Isabel Castellanos
LELeif-Christopher Engel
Leif-Christopher Engel
ALAnna Lena Lahmann
Anna Lena Lahmann
MJMichael Joner
Michael Joner
Extensive translational research has provided considerable progress regarding the understanding of atherosclerosis pathophysiology over the last decades. In contrast, implementation of molecular in vivo imaging remains highly limited. In that context, nanoparticles represent a useful tool. Their variable shape and composition assure biocompatibility and stability within the environment of intended use, while the possibility of conjugating different ligands as well as contrast dyes enable targeting of moieties of interest on a molecular level and visualization throughout various imaging modalities. These characteristics have been exploited by a number of preclinical research approaches aimed at advancing understanding of vascular atherosclerotic disease, in order to improve identification of high-risk lesions prior to oftentimes fatal thromboembolic events. Furthermore, the combination of these targeted nanoparticles with therapeutic agents offers the potential of site-targeted drug delivery with minimized systemic secondary effects. This review gives an overview of different groups of targeted nanoparticles, designed for in vivo molecular imaging of atherosclerosis as well as an outlook on potential combined diagnostic and therapeutic applications.

15 January 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ALAnna Lena Lahmann
Anna Lena Lahmann
DBDario Bongiovanni
Dario Bongiovanni
ABAnna Berkefeld
Anna Berkefeld
MKMaximilian Kettern
Maximilian Kettern
LMLucas Martinez
Lucas Martinez
MJMichael Joner
Michael Joner
Out-of-hospital cardiac arrest (OHCA) is one of the leading causes of death worldwide, with acute coronary syndromes accounting for most of the cases. While the benefit of early revascularization has been clearly demonstrated in patients with ST-segment-elevation myocardial infarction (STEMI), diagnostic pathways remain unclear in the absence of STEMI. We aimed to characterize OHCA patients presenting to 2 tertiary cardiology centers and identify predicting factors associated with survival. We retrospectively analyzed 519 patients after OHCA from February 2003 to December 2017 at 2 centers in Munich, Germany. Patients undergoing immediate coronary angiography (CAG) were compared to those without. Multivariate regression analysis and inverse probability treatment weighting (IPTW) were performed to identify predictors for improved outcome in a matched population. Immediate CAG was performed in 385 (74.1%) patients after OHCA with presumed cardiac cause of arrest. As a result of multivariate analysis after propensity score matching, we found that immediate CAG, return of spontaneous circulation (ROSC) at admission, witnessed arrest and former smoking were associated with improved 30-days-survival [(OR, 0.46; 95% CI, 0.26–0.84), (OR, 0.21; 95% CI, 0.10–0.45), (OR, 0.50; 95% CI, 0.26–0.97), (OR, 0.43; 95% CI, 0.23–0.81)], and 1-year-survival [(OR, 0.39; 95% CI, 0.19–0.82), (OR, 0.29; 95% CI, 0.12–0.7), (OR, 0.43; 95% CI, 0.2–1.00), (OR, 0.3; 95% CI, 0.14–0.63)]. In our study, immediate CAG, ROSC at admission, witnessed arrest and former smoking were independent predictors of survival in cardiac arrest survivors. Improvement in prehospital management including bystander CPR and best practice post-resuscitation care with optimized triage of patients to an early invasive strategy may help ameliorate overall outcome of this critically-ill patient population.

1 August 2016 in Revista Española de Cardiología (English Edition)
Verified
Journal Article
Closed access
Gjin NdrepepaGjin Ndrepepa
Gjin Ndrepepa
SBSiegmund Braun
Siegmund Braun
SCSalvatore Cassese
Salvatore Cassese
KMKatharina Mayer
Katharina Mayer
RLRaphaela Lohaus
Raphaela Lohaus
AKAdnan Kastrati
Adnan Kastrati

14 August 2020 in European Heart Journal
Verified
Journal Article
Open access
PDF file
MJMichael Joner
Michael Joner
ALAnna Lena Lahmann
Anna Lena Lahmann
MJMichael Joner
Michael Joner
This editorial refers to ‘Glucocorticoid-induced tumour necrosis factor receptor family-related protein (GITR) drives atherosclerosis in mice and is associated with an unstable plaque phenotype and cerebrovascular events in humans’† by A. Shami et al., on page 2938.